Edarbi

Utilised to manage elevated systemic blood pressure to alleviate cardiac strain and support vascular endothelial safety.

Dosage

Pack size

You will receive a quality generic equivalent of Edarbi, depending on stock.

Prescription and consultation requirements for Edarbi vary by destination and are determined by the fulfilment partner.

Edarbi details

Condition: Hypertension
Alternative names: azilsartan medoxomil
Therapeutic class: Angiotensin II Receptor Antagonist
Pharmacological class: ARB
Contraindications: pregnancy; concurrent use of aliskiren in diabetic patients
Minor side effects: dizziness; headache; cough
Moderate side effects: fatigue; hypotension; hyperkalaemia
Dosage forms: Tablet
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Originator: Takeda
Onset Time: 1–2 hours
Duration: 24 hours
Storage instructions: Store below 25°C.
Drug interactions: Lithium; Potassium Supplements; NSAIDs
Age restrictions: Approved for adults.

Serious side effects

angioedema, requires immediate medical attention; severe acute renal impairment, requires immediate medical attention

Patient summary

utilised to manage elevated systemic blood pressure to alleviate cardiac strain and support vascular endothelial safety.

Mechanism of action

Selectively blocks the binding of vasoconstricting angiotensin II to AT1 receptors in cardiac and vascular tissues.

Pregnancy and breastfeeding

TGA Category D: High risk of fetal toxicity and death. Contraindicated in pregnancy. Breastfeeding: Not recommended.

Edarbi is the originator brand name, made by Takeda. We use it to identify the medicine and are not affiliated with Takeda.

The fulfilment partner confirms whether the exact brand or an equivalent containing Azilsartan Medoxomil is offered.
The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
Check the final product details at checkout before confirming an order.